Literature DB >> 14628072

ATM gene and lymphoid malignancies.

F Gumy-Pause1, P Wacker, A-P Sappino.   

Abstract

Inherited biallelic mutations of the ATM (ataxia-telangiectasia mutated) gene cause ataxia-telangiectasia, a rare autosomal recessive disorder associated with a high incidence of childhood leukaemias and lymphomas, suggesting that ATM gene alterations may be involved in lymphomagenesis. Loss of heterozygosity at 11q22-23 (location of the ATM gene) is a frequent event in sporadic lymphoid tumours, and several studies have reported a high prevalence of ATM gene alterations in diverse sporadic lymphoproliferative disorders, adding evidence to the postulated contribution of ATM in the pathogenesis of these tumours. This mini-review will summarize the recently published data concerning the ATM gene in sporadic lymphoid malignancies and will discuss the apparent paradox between the predominance of nonsense mutations observed in patient with ataxia-telangiectasia and the high proportion of missense alterations found in sporadic lymphoid tumours.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14628072     DOI: 10.1038/sj.leu.2403221

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  35 in total

1.  Characterisation of ATM mutations in Slavic Ataxia telangiectasia patients.

Authors:  Jana Soukupova; Petr Pohlreich; Eva Seemanova
Journal:  Neuromolecular Med       Date:  2011-08-11       Impact factor: 3.843

Review 2.  Emerging non-transplant-based strategies in treating pediatric non-Hodgkin's lymphoma.

Authors:  Lia Gore; Tanya M Trippett
Journal:  Curr Hematol Malig Rep       Date:  2010-10       Impact factor: 3.952

3.  Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.

Authors:  Gerard Lozanski; Amy S Ruppert; Nyla A Heerema; Arletta Lozanski; David M Lucas; Amber Gordon; John G Gribben; Vicki A Morrison; Kanti M Rai; Guido Marcucci; Richard A Larson; John C Byrd
Journal:  Leuk Lymphoma       Date:  2012-06-02

4.  Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer.

Authors:  Ling Wang; Adam J Mosel; Gregory G Oakley; Aimin Peng
Journal:  Mol Cancer Ther       Date:  2012-09-12       Impact factor: 6.261

Review 5.  Ataxia-telangiectasia and related diseases.

Authors:  Pierre-Olivier Frappart; Peter J McKinnon
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease.

Authors:  Rosanna Beraldi; Chun-Hung Chan; Christopher S Rogers; Attila D Kovács; David K Meyerholz; Constantin Trantzas; Allyn M Lambertz; Benjamin W Darbro; Krystal L Weber; Katherine A M White; Richard V Rheeden; Michael C Kruer; Brian A Dacken; Xiao-Jun Wang; Bryan T Davis; Judy A Rohret; Jason T Struzynski; Frank A Rohret; Jill M Weimer; David A Pearce
Journal:  Hum Mol Genet       Date:  2015-09-15       Impact factor: 6.150

Review 7.  DNA repair deficiency in neurodegeneration.

Authors:  Dennis Kjølhede Jeppesen; Vilhelm A Bohr; Tinna Stevnsner
Journal:  Prog Neurobiol       Date:  2011-04-30       Impact factor: 11.685

8.  ATM in oral carcinogenesis: association with clinicopathological features.

Authors:  Yuan He; Qianming Chen; Bingqi Li
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-21       Impact factor: 4.553

Review 9.  Prognostic Factors for Chronic Lymphocytic Leukemia.

Authors:  Christopher Chen; Soham Puvvada
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

Review 10.  ATM and ataxia telangiectasia.

Authors:  Peter J McKinnon
Journal:  EMBO Rep       Date:  2004-08       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.